UroMed Partners with PatientPoint and Cure Medical to Provide Exam Room Education Materials

Beginning November 1st, thousands of urology offices around the country will offer valuable patient education material from UroMed and Cure Medical. This information will be provided by PatientPoint, a leader in point-of-care patient and physician engagement solutions.  Participating offices in the PatientPoint Urology Exam Room Network will be able to offer patients comprehensive health information on catheterization and incontinence.

“There is a great need for education and quality assurance when it comes to catheterization, and there are a large number of urology patients requiring catheters,” said John Anderson, president and CEO of Cure Medical. “Cure Medical is pleased to be part of the PatientPoint program to help end users get the high quality urologic product they need as easily as possible. PatientPoint is another way Cure Medical can reach our customers who need these products to live long, healthy lives.”

“Ongoing education and dedicated patient support are keystones of the overall commitment that UroMed makes to customer care,” said Lisa Wells, director of marketing for UroMed. “We recognize PatientPoint as a premier provider and developer of patient education, and we are thrilled to help provide these new educational resources within their network. PatientPoint is the only company which can help us advance our messages in the privacy of the exam room every day to educate catheter users in urology offices nationwide.”

“UroMed is the first home medical equipment company to sponsor the PatientPoint network as a way to better educate and serve their customers in urology exam rooms,” said Linda Ruschau, executive vice president, client solutions at PatientPoint. “PatientPoint urologists see approximately 2.4 million patients annually, and we are confident that PatientPoint will help UroMed/Cure Medical address their customers’ needs. We are proud of this new partnership and look forward to mutual success.”

About UroMed

 UroMed is one of the nation’s leading providers of single-use catheters, urological and disposable medical supplies, including intermittent catheters, closed system catheters, condom catheters, pediatric catheters and continence care products. UroMed is a nationally accredited organization, a Medicare provider and a participant in most state Medicaid plans. UroMed also partners with thousands of private health insurance providers and health plans to provide patients with single-use catheters, catheter kits and incontinence products. UroMed has six staffed regional offices located in Richmond, VA; Greenville, SC; Jacksonville, FL; Dallas, TX; Knoxville, TN; and Baton Rouge, LA; enabling next-day delivery after a customer’s initial medical supply order. For more information, please visit www.uromed.com or call 1-800-841-1233.

About Cure Medical

 Cure Medical manufactures catheters and is the first and only company to manufacture all of its products without DEHP, latex and BPA. Cure Medical donates 10% of its net profits to scientific research, seeking to develop treatments for spinal cord injuries and related neurological disorders. The use of Cure Medical products can result in new dollars devoted toward research that will develop a cure. Learn more at www.curemedical.com or call 1-800-570-1778.

About PatientPoint®

PatientPoint is an innovator and leading provider of patient and physician engagement solutions at the point of care. The company serves more than 61,000 physicians across all programs, and more than 550 hospitals throughout the U.S., and impacts over 456 million healthcare consumer exposures each year. The PatientPoint award-winning health information and care coordination products drive meaningful outcomes for patients, healthcare providers and program sponsors. For more information, visit www.patientpoint.com.

 

UroMed’s David Williams Wins 4th Straight US Open Wheelchair Tennis Tournament

On October 1st, UroMed’s own David Williams competed in and WON the Men’s Wheelchair Division A Singles tournament at the 2012 US OPEN USTA Wheelchair Championships in St. Louis. This is David’s 4th consecutive national championship win. Congrats David!

David fully believes in the I-Can Attitude!

David fully believes in the I-Can Attitude!

David contracted Transverse Myelitis when he was 14 and has been in a wheelchair since. He originally had aspirations of playing wheelchair basketball and played that sport for several years. At the age of 17, he started playing tennis and hasn’t stopped since. UroMed featured David as a Hometown Hero last year. Click here to read his story.

See David talk about his life-changing experiences with Transverse Myelitis and wheelchair tennis in this interview filmed by 11Alive NBC News here in Atlanta:

About The USTA

The USTA’s mission is To Promote and Develop the Growth of Tennis.

The United States Tennis Association (USTA) is the national governing body for the sport of tennis and the recognized leader in promoting and developing the sport’s growth on every level in the United States, from local communities to the crown jewel of the professional game, the US Open.

David plays with and against some of the best wheelchair tennis competitors in the nation.

David plays with and against some of the best wheelchair tennis competitors in the nation.

Established in 1881, the USTA is a progressive and diverse not-for-profit organization whose volunteers, professional staff, and financial resources support the singular mission.

The USTA is the largest tennis organization in the world, with 17 geographical sections, more than 750,000 individual members and 7,000 organizational members, thousands of volunteers, and a professional staff dedicated to growing the game.

The USTA: Making Tennis Make A Difference!

About Transverse Myelitis

Transverse myelitis is a neurological disorder caused by inflammation across both sides of one level, or segment, of the spinal cord. The term myelitis refers to inflammation of the spinal cord; transverse simply describes the position of the inflammation, that is, across the width of the spinal cord. Attacks of inflammation can damage or destroy myelin, the fatty insulating substance that covers nerve cell fibers. This damage causes nervous system scars that interrupt communications between the nerves in the spinal cord and the rest of the body.

Symptoms of transverse myelitis include a loss of spinal cord function over several hours to several weeks. What usually begins as a sudden onset of lower back pain, muscle weakness, or abnormal sensations in the toes and feet can rapidly progress to more severe symptoms, including paralysis, urinary retention, and loss of bowel control. Although some patients recover from transverse myelitis with minor or no residual problems, others suffer permanent impairments that affect their ability to perform ordinary tasks of daily living. Most patients will have only one episode of transverse myelitis; a small percentage may have a recurrence.

The segment of the spinal cord at which the damage occurs determines which parts of the body are affected. Nerves in the cervical (neck) region control signals to the neck, arms, hands, and muscles of breathing (the diaphragm). Nerves in the thoracic (upper back) region relay signals to the torso and some parts of the arms. Nerves at the lumbar (mid-back) level control signals to the hips and legs. Finally, sacral nerves, located within the lowest segment of the spinal cord, relay signals to the groin, toes, and some parts of the legs. Damage at one segment will affect function at that segment and segments below it. In patients with transverse myelitis, demyelination usually occurs at the thoracic level, causing problems with leg movement and bowel and bladder control, which require signals from the lower segments of the spinal cord.

Transverse myelitis occurs in adults and children, in both genders, and in all races. No familial predisposition is apparent. A peak in incidence rates (the number of new cases per year) appears to occur between 10 and 19 years and 30 and 39 years. Although only a few studies have examined incidence rates, it is estimated that about 1,400 new cases of transverse myelitis are diagnosed each year in the United States, and approximately 33,000 Americans have some type of disability resulting from the disorder.

Source: National Institute of Neurological Disorders and Stroke

UroMed Community Giving

David Williams was sponsored by UroMed to attend this tennis tournament. UroMed is honored to support numerous charities and sports programs nationwide in the communities that we serve.

The company focuses its community efforts on three primary areas:

  • Condition-related associations that focus on education, awareness and support
  • Sports programs for the disabled
  • Leadership and motivational programs for disabled youth

Additionally, many of our employees volunteer their time and efforts at various community events. Many of our employees have a personal connection to the following non-profit organizations, as 20% of our customer care associates either has a disability or has a family member with a disabling condition.

Please contact us if you would like to invite UroMed to sponsor your organization or event.


Switch to our mobile site